Coral's API range includes Corticosteroids, Antihistamines. Hormones and Antineoplastics.
01 1Coral Drugs Private Limited
02 1VAMSI LABS LIMITED.
03 1Farmabios S.p.A.
04 1Wavelength Enterprises LTD
05 1Symbiotec Pharmalab Private Limited
06 1Aarti Pharmalabs Limited
07 1Amphastar Nanjing Pharmaceuticals, Inc.
08 1Aurisco Pharmaceutical Co.,Ltd
09 1Cipla Ltd.
10 1Curia Spain S.A.U.
11 1Fagron Inc
12 1Glaxo Operations UK Ltd
13 1Glaxo Wellcome Manufacturing Pte. Ltd
14 1Hikma Pharmaceuticals LLC
15 1Hovione FarmaCiencia SA
16 1Hovione PharmaScience Limited
17 3Industriale Chimica s.r.l.
18 1LETCO MEDICAL, LLC
19 1Medisca Inc
20 1NEWCHEM SPA
21 1Professional Compounding Centers of America dba PCCA
22 1STERLING SPA
23 1Sicor de Mexico S.A. de C.V
24 2Sterling S.p.A.
01 5FLUTICASONE PROPIONATE
02 10Fluticasone Propionate
03 5Fluticasone Propionate Micronized
04 3Fluticasone propionate
05 1Fluticasone propionate ,USP (Micronized)
06 3fluticasone propionate
01 1China
02 1France
03 1Germany
04 5India
05 7Italy
06 1Mexico
07 1Netherlands
08 2Portugal
09 4U.S.A
10 4United Kingdom
NDC Package Code : 49076-5501
Start Marketing Date : 2018-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
FLUTICASONE PROPIONATE-17.BETA.-CARBOXYLIC ACID
NDC Package Code : 66412-0679
Start Marketing Date : 2023-09-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 46439-8729
Start Marketing Date : 2007-04-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 58175-0361
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 22552-0043
Start Marketing Date : 2015-01-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-0200
Start Marketing Date : 2005-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 16812-005
Start Marketing Date : 2022-01-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50909-5175
Start Marketing Date : 2002-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2760
Start Marketing Date : 2014-05-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 24002-0003
Start Marketing Date : 2009-08-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Flixotide Inhaler manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flixotide Inhaler, including repackagers and relabelers. The FDA regulates Flixotide Inhaler manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flixotide Inhaler API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flixotide Inhaler manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flixotide Inhaler supplier is an individual or a company that provides Flixotide Inhaler active pharmaceutical ingredient (API) or Flixotide Inhaler finished formulations upon request. The Flixotide Inhaler suppliers may include Flixotide Inhaler API manufacturers, exporters, distributors and traders.
click here to find a list of Flixotide Inhaler suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Flixotide Inhaler as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Flixotide Inhaler API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Flixotide Inhaler as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Flixotide Inhaler and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Flixotide Inhaler NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Flixotide Inhaler suppliers with NDC on PharmaCompass.
We have 21 companies offering Flixotide Inhaler
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?